Skip to main content
SpringerLink
Log in
Book cover

Prostate Cancer pp 65–81Cite as

Prostate Cancer Screening

  • Chapter

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 175))

Abstract

Prostate cancer is a major healthcare problem worldwide, especially in the industrialized countries of the Western world. Prostate cancer has become the most common type of cancer among men and is the second leading cause of years of life lost from cancer in males [58]. Incidence estimates for the year 2000 indicate prostate cancer newly affected 542,990 men worldwide that year, 204,313 of whom have since died. Early detection and treatment of prostate cancer could theoretically reduce the burden of this potentially disabling and deadly disease. However, because no conclusive, direct evidence demonstrates that early detection and treatment improve length or quality of life, the value of prostate cancer screening remains controversial.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101

    Article  PubMed  CAS  Google Scholar 

  2. American Cancer Society (2002) Cancer facts and figures, 2001–2002. http://www.cancer.org. Cited 1 March 2006

    Google Scholar 

  3. Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schonitzer D, et al (2001) Prostate cancer mortality after introduction of prostatespecific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58:417–424

    Article  PubMed  CAS  Google Scholar 

  4. Benson MC, Whang IS, Pantuck A, et al (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147:815–816

    PubMed  CAS  Google Scholar 

  5. Bill-Axelson A, Holmberg L, Ruutu M, et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984

    Article  PubMed  CAS  Google Scholar 

  6. Boer R, Schröder FH (1999) Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction. Prostate 40:130–134

    Article  PubMed  CAS  Google Scholar 

  7. Bozeman CB, Carver BS, Caldito G, Venable DD, Eastham JA (2005) Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/ml. Urology 66:803–807

    Article  PubMed  Google Scholar 

  8. Brawer MK, Beatie J, Wener MH, Vessella RL, Preston SD, Lange PH (1993) Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 150:106–109

    PubMed  CAS  Google Scholar 

  9. Carter HB (2001) Rationale for earlier and less frequent prostate cancer screening. Urology 58:639–641

    Article  PubMed  CAS  Google Scholar 

  10. Carter HB, Pearson JD, Metter EJ, Brant LJ, Andres R, Fozard JL, Walsh PV (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215–2220

    Article  PubMed  CAS  Google Scholar 

  11. Catalona WJ, Richie JP, de Kernion JB, et al (1994) Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 152:2031–2036

    PubMed  CAS  Google Scholar 

  12. Catalona WJ, Partin AW, Slawin KM, Brawer M, et al (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–1547

    Article  PubMed  CAS  Google Scholar 

  13. Coley CM, Barry MJ, Fleming C, Mulley AG (1997) Early detection of prostate cancer. I. Prior probability and effectiveness of tests. Ann Intern Med 126:394–406

    PubMed  CAS  Google Scholar 

  14. Concato J (1997) What is a screening test? Misclassification bias in observational studies of screening for cancer. J Gen Intern Med 12:607–612

    Article  PubMed  CAS  Google Scholar 

  15. De Koning HJ, Auvinen A, Sanchez AB, et al (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97:237–244

    Article  PubMed  CAS  Google Scholar 

  16. Dennis LK, Resnick MI (2000) Analysis of recent trends in prostate cancer incidence and mortality. Prostate 42:247–252

    Article  PubMed  CAS  Google Scholar 

  17. Ellis WJ, Brawer MK (1994) The significance of isoechoic prostatic carcinoma. J Urol 152:2304–2307

    PubMed  CAS  Google Scholar 

  18. Fair WR, Fleshner NE, Heston W (1997) Cancer of the prostate: a nutritional disease? Urology 50:840–848

    Article  PubMed  CAS  Google Scholar 

  19. Feuer EJ, Merrill RM, Hankey BF (1999) Cancer surveillance series: interpreting trends in prostate cancer-part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 91:1025–1032

    Article  PubMed  CAS  Google Scholar 

  20. Friedman G, Hiatt R, Quesenberry C, Selby J (1991) Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 337:1526–1529

    Article  PubMed  CAS  Google Scholar 

  21. Goldenberg SL, Thompson IM (2001) Prostate cancer: all you need to know to take an active part in your treatment. Intelligent Patient Guide, Vancouver, pp 1–269

    Google Scholar 

  22. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics 2001. CA Cancer J Clin 51:15–36

    Article  PubMed  CAS  Google Scholar 

  23. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC (2001) Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the prostate outcomes study. J Clin Oncol 19:2517–2526

    PubMed  CAS  Google Scholar 

  24. Hankey BF, Feuer EJ, Clegg LX, et al (1999) Cancer surveillance series: interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst 91:1017–1021

    Article  PubMed  CAS  Google Scholar 

  25. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartmann AM, et al (1998) Prostate cancer and supplementation with alphatocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440–446

    Article  PubMed  CAS  Google Scholar 

  26. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Caroll PR (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703–709

    PubMed  CAS  Google Scholar 

  27. Hsing AW, Tsao L, Devesa SS (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85:60–67

    Article  PubMed  CAS  Google Scholar 

  28. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al (1995) Incidence of prostate cancer diagnosis in the years before and after serum prostate-specific antigen testing. JAMA 274:1445–1449

    Article  PubMed  CAS  Google Scholar 

  29. Jacobsen SJ, Bergstralh EJ, Katusic SK, et al (1998) Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology 52:173–179

    Article  PubMed  CAS  Google Scholar 

  30. Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, et al (2004) Natural history of early localized prostate cancer. JAMA 291:2713–2719

    Article  PubMed  CAS  Google Scholar 

  31. Katz DA, McHorney CA, Schapira MM (1998) Health-related quality of life in men with localized prostate cancer. J Gen Intern Med 13(Suppl):16–24

    Google Scholar 

  32. Kurhanewicz J, Vigneron D, Hricak H, Parivar F, Nelson SJ, Shinohara K, Caroll PR (1996) Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 200:489–496

    PubMed  CAS  Google Scholar 

  33. Labrie F, Candas B, Dupont A, et al (1999) Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate 38:83–91

    Article  PubMed  CAS  Google Scholar 

  34. Lee AK, D’Amico AV (2005) Utility of prostatespecific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy. J Clin Oncol 23:8192–8197

    Article  PubMed  Google Scholar 

  35. Levine MA, Ittman M, Melamed J, et al (1998) Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159:471–476

    Article  PubMed  CAS  Google Scholar 

  36. Lichtenstein P, Holm NV, Verkasolo PK, Iliadou A, Kaprio J, Koskenvou M, et al (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    Article  PubMed  CAS  Google Scholar 

  37. Maattanen L, Auvinen A, Stenman UH, et al (1999) European randomized study of prostate cancer screening: first year results of the Finnish trial. Br J Cancer 79:1210–1214

    Article  PubMed  CAS  Google Scholar 

  38. Mettlin C, Lee F, Draep J, Murphy GP (1991) The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 67:2949–2958

    Article  PubMed  CAS  Google Scholar 

  39. Mettlin C, Jones GW, Murphy GP (1993) Trends in prostate cancer care in the United States, 1974–1990: observations from the patients care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 43:83–91

    PubMed  CAS  Google Scholar 

  40. Nielsen C, Lang RS (1999) Principles of screening. Med Clin North Am 83:1323–1338

    Article  PubMed  CAS  Google Scholar 

  41. Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE (1996) Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: a pathological analysis. J Urol 155:1336–1339

    Article  PubMed  CAS  Google Scholar 

  42. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, et al (2005) 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 173:1701–1705

    Article  PubMed  Google Scholar 

  43. Pienta KJ, Esper PS (1993) Risk factors for prostate cancer. Ann Intern Med 118:793–803

    PubMed  CAS  Google Scholar 

  44. Prestigiacomo AF, Stamey TA (1996) Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng/ml range in male volunteers. J Urol 155:1977–1980

    Article  PubMed  CAS  Google Scholar 

  45. Punglia RS, D’Amico AV, Catalona WJ, et al (2003) Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 349:335–342

    Article  PubMed  Google Scholar 

  46. Richert-Boe KE, Humphrey LL, Glass AG, Weiss NS (1998) Screening digital rectal examination and prostate cancer mortality: a case-control study. J Med Screen 5:99–103

    PubMed  CAS  Google Scholar 

  47. Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ (1999) Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol 161:529–533

    Article  PubMed  CAS  Google Scholar 

  48. Scardino PT, Weaver R, Hudson MA (1992) Early detection of prostate cancer. Hum Pathol 23:211–222

    Article  PubMed  CAS  Google Scholar 

  49. Schmidt JD, Mettlin CJ, Natarajan N, et al (1986) Trends in patterns of care for prostate cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol 136:416–421

    PubMed  CAS  Google Scholar 

  50. Schröder FH, van der Maas P, Beemsterboer P, Kruger AE, Hoedemaeker R, Rietbergen J, et al (1998) Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 90:1817–1820

    Article  PubMed  Google Scholar 

  51. Schröder FH, Alexander FE, Bangma CH, Hugoson J, Smith DS (2000) Screening and early detection of prostate cancer. Prostate 44:255–263

    Article  PubMed  Google Scholar 

  52. Schröder FH, Wildhagen MF (2001) Screening for prostate cancer: evidence and perspectives. BJU Int 88:811–817

    Article  PubMed  Google Scholar 

  53. Schulmann CC, Ekane S, Zlotta AR (2001) Nutrition and prostate cancer: evidence or suspicion? Urology 58:318–334

    Article  Google Scholar 

  54. Smith DS, Catalona WJ, Herschman JD (1996) Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA 276:1309–1315

    Article  PubMed  CAS  Google Scholar 

  55. Steineck G, Helgesen F, Adolfsson J, Dickman PW, et al (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347:790–796

    Article  PubMed  Google Scholar 

  56. Stanford JL, Stephenson RA, Coyle LM, et al (1998) Prostate cancer trends 1973–1995, SEER program. National Cancer Institute, Bethesda

    Google Scholar 

  57. Stenman UH, Leinonen J, Alfthan H, et al (1991) A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222–226

    PubMed  CAS  Google Scholar 

  58. Stephenson RA (2002) Prostate cancer trends in the era of prostate specific antigen: an update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 29:173–178

    Article  PubMed  Google Scholar 

  59. Vis AN, Hoedemaeker RF, Roobol M, van der Kwast TH, Schröder FH (2001) Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml). Prostate 47:252–261

    Article  PubMed  CAS  Google Scholar 

  60. Whitmore WF (1994) Localized prostate cancer: management and detection issues. Lancet 343:1263–1267

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Jahn Ferenc South-Pest Hospital, Köves Utca 2-4, 1204, Budapest, Hungary

    P. Tenke PhD, P. Balint PhD & B. Kovacs PhD

  2. Department of Chemotherapy and Clinical Pharmacology, National Institute of Oncology, Rath Gy. Utca 7-9, 1122, Budapest, Hungary

    J. Horti PhD

Authors
  1. P. Tenke PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Horti PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Balint PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Kovacs PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, 52621, Israel

    Jacob Ramon MD

  2. Lange Gasthuisstraat 35-37, 2000, Antwerp, Belgium

    Louis J. Denis MD, FACS (Director Oncology Centre Antwerp Secretary Europa Uomo) (Director Oncology Centre Antwerp Secretary Europa Uomo)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tenke, P., Horti, J., Balint, P., Kovacs, B. (2007). Prostate Cancer Screening. In: Ramon, J., Denis, L.J. (eds) Prostate Cancer. Recent Results in Cancer Research, vol 175. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-40901-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-40901-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40897-0

  • Online ISBN: 978-3-540-40901-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation